SYP and Alzheimer disease: Goetzl and coworkers (2016) [96] demonstrated that the levels of synaptophysin, synaptopodin, synaptotagmin-2, and neurogranin in L1CAM+ EVs were significantly lower in patients with frontotemporal dementia and AD than in controls.